-+ 0.00%
-+ 0.00%
-+ 0.00%
Lytix Biopharma Raises NOK80 Million via Private Placement, Retail Offer
Share
Listen to the news
12:24 AM EST, 11/18/2026 (MT Newswires) -- Lytix Biopharma (LYTIX.OL) raised 80 million Norwegian kroner in a private placement and retail offering, the clinical-stage biotechnology company said Wednesday. The private placement raised 74.7 million kroner by allocating 9.34 million shares at 8 kroner apiece, while the retail offering raised an additional 5.3 million kroner. The proceeds will support preparations for a planned phase 3 study of ruxotemitide in neoadjuvant melanoma, the Aletta phase 2 study, development of LTX-401 toward phase 1, and general corporate purposes. Lytix also plans a subsequent offering of up to 15 million kroner at 8 kroner per share, targeting eligible existing shareholders who did not participate in the private placement or retail offering.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending